SC
Stanley T Crooke
Exec Chairman of the BoardDirector

Stanley T Crooke insider trades: Ionis Pharmaceuticals (IONS) stock buys and sales

Exec Chairman of the Board, Ionis Pharmaceuticals Last trade Jan 26, 2021 118 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
163
Open-market trades
since 2006
4
Companies
last trade 2021

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Stanley reports to the SEC

Open-market buys and sales

163 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jan 26, 2021IONS↓ Sell10b5-1$1.8M
Jan 22, 2021IONS↓ Sell10b5-1$4.6M
Dec 17, 2020IONS↓ Sell10b5-1$71K
Dec 15, 2020IONS↓ Sell10b5-1$1.9M
Dec 7, 2020IONS↓ Sell10b5-1$568K
Nov 25, 2020IONS↓ Sell10b5-1$650K
Nov 24, 2020IONS↓ Sell10b5-1$713K
Nov 23, 2020IONS↓ Sell10b5-1$25K
Sep 22, 2020IONS↓ Sell10b5-1$2.5M
Sep 21, 2020IONS↓ Sell10b5-1$100K
Jun 25, 2020IONS↓ Sell10b5-1$890K
Jun 19, 2020IONS↓ Sell10b5-1$1.5M
Jun 17, 2020IONS↓ Sell10b5-1$117K
Mar 25, 2020IONS↓ Sell10b5-1$705K
Mar 25, 2020IONS↓ Sell10b5-1$47K
Mar 19, 2020IONS↓ Sell10b5-1$678K
Mar 19, 2020IONS↓ Sell10b5-1$45K
Mar 17, 2020IONS↓ Sell10b5-1$912K
Aug 21, 2019IONS↓ Sell10b5-1$1.4M
Aug 20, 2019IONS↓ Sell10b5-1$142K
Jul 18, 2019IONS↓ Sell10b5-1$703K
Apr 16, 2019IONS↓ Sell10b5-1$2.5M
Apr 16, 2019IONS↓ Sell10b5-1$170K
Feb 26, 2019IONS↓ Sell10b5-1$4.7M
Feb 13, 2019IONS↓ Sell10b5-1$2.4M
Feb 13, 2019IONS↓ Sell10b5-1$414K
Apr 17, 2018IONS↓ Sell10b5-1$442K
Apr 17, 2018IONS↓ Sell10b5-1$178K
Jan 15, 2018IONS↓ Sell$823K
Jan 15, 2018IONS↓ Sell$34K
Jan 8, 2018IONS↓ Sell10b5-1$520K
Jan 8, 2018IONS↓ Sell10b5-1$52K
Jan 3, 2018IONS↓ Sell10b5-1$1.0M
Jan 3, 2018IONS↓ Sell10b5-1$100K
Oct 13, 2017IONS↓ Sell10b5-1$892K
Oct 13, 2017IONS↓ Sell10b5-1$89K
Oct 4, 2017IONS↓ Sell10b5-1$1.3M
Oct 4, 2017IONS↓ Sell10b5-1$132K
Jul 20, 2017IONS↓ Sell10b5-1$554K
Jul 20, 2017IONS↓ Sell10b5-1$55K
Jul 17, 2017IONS↓ Sell10b5-1$787K
Jul 17, 2017IONS↓ Sell10b5-1$79K
Jul 3, 2017IONS↓ Sell10b5-1$782K
Jul 3, 2017IONS↓ Sell10b5-1$78K
Apr 25, 2017IONS↓ Sell10b5-1$717K
Apr 25, 2017IONS↓ Sell10b5-1$72K
Apr 19, 2017IONS↓ Sell10b5-1$216K
Apr 19, 2017IONS↓ Sell10b5-1$22K
Apr 13, 2017IONS↓ Sell10b5-1$814K
Apr 13, 2017IONS↓ Sell10b5-1$61K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other IONS insiders

Open-market trades in the last 12 months

About Stanley T Crooke's insider trades

Stanley T Crooke is Exec Chairman of the Board at Ionis Pharmaceuticals (IONS). Since Nov 13, 2006, Stanley has reported 1 open-market purchase worth $3.0M and 162 sales worth $94.7M on SEC Form 4. There have been no open-market trades in the last 12 months.

149 sales (96% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.

Their filings also include option exercises (87 filings), grants and awards (32 filings), shares withheld for taxes (3 filings), conversions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every IONS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.